Medpace Holdings, Inc.

Total Valuation

Medpace Holdings, Inc. carries a market capitalization of 16.16B, placing it among publicly traded companies globally. Its enterprise value stands at 14.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Medpace Holdings, Inc. currently has 27.91M shares outstanding.

Valuation Ratios

Medpace Holdings, Inc. trades at a trailing price-to-earnings ratio of 30.45. The price-to-sales ratio is 5.38, and the price-to-book ratio stands at 34.07.

Enterprise Valuation

On an enterprise value basis, Medpace Holdings, Inc. trades at an EV/EBITDA multiple of 23.56 and an EV/FCF ratio of 19.02. The EV/Sales ratio of 5.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.68 provides insight into valuation relative to core operating earnings.

Financial Position

Medpace Holdings, Inc. maintains a current ratio of 0.73, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

Medpace Holdings, Inc. posts a return on equity of 162.15 and a return on invested capital of 112.48.

Taxes

Over the trailing twelve months, Medpace Holdings, Inc. has paid 107.42M in income taxes, reflecting an effective tax rate of 17.94.

Stock Price Statistics

Medpace Holdings, Inc.'s stock has gained approximately 26.19806% over the past 52 weeks. The 50-day moving average sits at 531.60, while the 200-day moving average is 519.94.

Income Statement

Over the trailing twelve months, Medpace Holdings, Inc. generated 2.78B in revenue and converted that into 491.50M in net income, yielding earnings per share of 17.05. EBITDA reached 611.20M, while operating income came in at 583.40M.

Balance Sheet

Medpace Holdings, Inc. holds 502.69M in cash and equivalents against 120.10M in total debt, resulting in a net debt position of -502.69M. Total book value stands at 433.86M, with working capital of -385.14M providing operational flexibility.

Cash Flow

Medpace Holdings, Inc. produced 752.66M in operating cash flow over the past twelve months. After subtracting -4.54M in capital expenditures, free cash flow totaled 748.12M - equivalent to 26.47 per share.

Margins

Medpace Holdings, Inc. operates with a gross margin of 28.76, reflecting its pricing power and cost economics. The operating margin of 20.97 and net profit margin of 17.67 provide insight into operational efficiency.

Dividends & Yields

Scores

Medpace Holdings, Inc. posts an Altman Z-Score of 8.06, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.